Agenda

• Patients are the new partners and they wield significant influence. Learn how creating effective change in your marketplace can be achieved in partnership with patients.
• Learn that the evolution of pharma is necessary to deliver better more effective interventions, drive innovation and deliver healthcare outcomes that patients want.
• Understand how patient trends are changing in terms of their influence, their use of technology, their education and their lifestyle expectations
• Successfully leverage these opportunities by building valuable relationships with key organisations

• The emergence of the patient as the new dominant stakeholder in healthcare
• How pharma can begin to build their strategy to balance patient, payer and physician needs
• Case example: how one company are re-organising their core functions to be more patient orientated

• Discover the value of the nurse-patient relationship and they key role they play in ensuring adherence
• Learn how pharma can successfully engage and support their nurses in driving adherence education and understanding
• Case example: the crucial role of the nurse in your patient programmes

• Discover common challenges and frustrations experienced as a nurse in delivering patient support, and ways pharma can help them overcome these
• What are the reasons for non-adherence from the nurse perspective?
• Discover they key elements of a supportive, mutually beneficial nurse programme

• Learn how patient group support builds credibility into adherence programmes
• Discover the goals and objectives pharma share with patient groups
• Creating win-win strategies by embedding patient group insight from the beginning
• Leverage patient group partnerships to increase the quality and effect of patient education; ensure adherence to your health management programmes

• Challenges of globalising adherence solutions and lessons learned
• The global/local market tension
• Client Case Studies: Bottom up - Making a successful local program and taking it global

 Aunia Grogan, CEO, Atlantis Healthcare

Applying behavior change techniques, cognitive behavioral therapy and motivational interviewing, in pharmaceutical programs:
Examples with Atlantis Healthcare’s clinical team:

Dr Lina Eliasson: Non-adherence to oral oncology agents and the use of Medication Events Measurement
Christina Jackson: Non-adherence in Inflammatory Bowel Disease - the causes of non-adherence, and effective interventions to reduce concerns about medication
Dr Anna Baker: HCP led adherence interventions

• Understand your stakeholders
• Build the value proposition with the healthcare professional in mind
• Train the sales force to effectively position the value proposition
• Delegates are invited to bring their specific adherence program enrolment challenges and we will workshop them!

Carole North, Director, 90TTENHealthcare

• Insight into patient programs in Canada: incorporate patient information into your long term strategy
• How to successfully structure your long term adherence program to support a global campaign
• Patient outcomes results; what works and what doesn't!

• Hear about a new peer reviewed Risk Stratification Matrix that helps tailor support to the individual
• Learn how working collaboratively with a wide range of stakeholders can give you the best adherence programme
• Hear about a new adherence line for patients being treated for hepatitis C and the get the latest evaluation results
• Get the patient's perspective - what elements of an adherence programme are most important to the patient

Mehmood Syed, Medical Director, Bupa Home Healthcare

• Overcome the challenge of communicating cost savings to payers in your long term adherence programmes
• Discover how you can ensure stakeholder support by sharing ownership and insight in the programme design stage
• How to gain leverage with payers: examples of patient support programmes that have achieved cost savings and built value to payers

Omar Ali, Formulary Development Pharmacist, NHS Trust

• Patient evaluation: discover what your patients have to say about their experience with the interventions they have encountered
• Find out where patients turn for support, motivation and guidance and the opportunities that exist for pharma to support them
• The patient perspective of non-compliance; why it is they often fail to adhere and what digital devices exist that improve this

• The benefits of bringing patients together in an independent forum and how this motivates, empowers and drives adherence in your patients
• How you can utilise online patient information to identify trends and opportunities to build more detailed and informed patient profiles
• Case example; how technology has enhanced patient outcomes in a specific adherence programme

• How to overcome the challenges of compliance to deliver effective programmes that engage patients whilst still following EU law and guidelines
• Regulation update: what is new in regulations across Europe and how this affects your future digital patient strategy
• Examples of compliant apps, digital engagement and social media campaigns- and what you can learn from them

• See how patient centricity entered every stage of pharma planning and future development
• Learn ways that Teva have reorganized their global system to meet MS patient needs on a local level
• Explore core patient needs and align strategy with those needs

Lilac Mandeles, Senior Global Strategic Marketing Manager, Teva

• Integrate the patient and physician perspective into your programme to build mutual benefit and ensure patient support
• Learn how mobile technology and digital platforms have improved patient education and compliance
• Case example: integrating technology in the home to increase compliance knowledge, feedback and improve interventions

• Discover the new generation of patients, how they communicate, learn and manage their health
• How pharma have begun to utilise new communication channels- mobile, digital platforms, social media and gaming
• Learn how these new platforms can enhance your existing patient strategy, targeting and communication approach
• The new European Patients Academy on Therapeutic Innovation (EUPATI); aims objectives, and opportunity

Jan Geissler, Co-Founder, CML Advocates Network & LeukaNet

• Who are Doro
• What is the mHealth strategy for senior users?
• What are the drivers for a different and disruptive approach from Pharma towards seniors?
• Why is usability of device and application key for Pharma who wish to engage with senior consumers?
• The Pharma case study – medication adherence in action for seniors.
• The device and application environment – usability as key and how it can be a digital success story for Pharma.

• Lysosomal storage diseases – the indication and its challenges, market environment and the need to support physicians and patients
• Joint idea creation and development of a unique patient centric Coaching project by three stakeholders
• Implementation of the service in the field
• First results of and future outlook after the pilot program

Birgit Bering, Manager Health Care Services, Genzyme
Kathrin Heinritz, Global Business Development Manager Health Management Services , Pharmexx

Discover the most appropriate method of measuring your individual interventions

• Identify the most important KPIs for your programme
• How ensure the correct KPIs and measurement metrics are in pace before the launch of your patient programme

Caroline Brocklehurst, CF Patient
Tom Grew, University College London Hospital

Quantifying Adherence Program Results

• Powerful influence
• Measure to manage
• Quantifying improved adherence and linking to improved disease outcomes
• Quantifying to the right stakeholders, including salesforce, doctor, and funder.

Cassie Schutte, CEO, Health Window

Discuss and debate the most common reasons for non-adherence. Learn what is new in these areas, and have your say on what the solutions could be

Sign-up sheets available at the registration desk- and more info below

Memory- forgetfulness

• Discover the packaging tools, apps, devices and other interventions that exist to remind patients to take medication
• Have your say: do you think that memory is the real reason for non- adherence?
• When are reminders considered invasive, and how to gauge what level of intervention is needed and in what cases

• The important factors when building patient tolls
• How to engage HCPs and patients with your tools and platforms
• Successfully gain support and build a following by engaging patient groups

• Ways to ensure your patients receive relevant and effective materials at the most
• Discover the steps you need to take to tailor your patient messages to specific patient segments
• How to utilise HCP's and other patient touch points to ensure maximum patient education and communication

• Ways to minimise misinterpretation of treatment and obstacles to adherence through state-of-the-art packaging solutions
• Understand the ROI in focusing on additional packaging trials - see the cost-benefit for your patient and brand